Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

Source: Nasdaq GlobeNewswire / 14 Sep 2021 02:00:00   America/New_York